Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis
- PMID: 17899211
- DOI: 10.1007/s00467-007-0586-z
Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis
Abstract
The aims of this study were (1) to ascertain ciclosporin C(2) levels currently being achieved in children with steroid-sensitive nephrotic syndrome (SSNS) and renal transplants (RTs), (2) to determine the feasibility of the use of finger-prick samples for the measurement of ciclosporin levels, and (3) to identify any correlation between hypertrichosis or gingival overgrowth (GO) and level of ciclosporin 2 h post-dose (C(2)). Seventy-two children (39 with SSNS, 33 with RT) participated. Ciclosporin 12 h trough (C(12)) and C(2) levels were measured in venous and finger-prick samples by high-performance liquid chromatography tandem mass spectroscopy. Photographs of the teeth and back were taken for assessment of GO and hypertrichosis. Mean (+/-SD) C(2) levels in the SSNS and RT groups were 512 (+/-181) microg/l and 471 (+/-229) microg/l. There was a highly significant relationship between venous and finger-prick ciclosporin levels (r(2) = 0.96, P < 0.0001). Fourteen children had severe GO. There was a small, though statistically significant, impact of ciclosporin level on GO (C(2) r(2) = 0.12, P = 0.003 and C(12) r(2) = 0.06, P = 0.038) but no correlation with dose (milligrammes per kilogramme per day or milligrammes per square metre per day) or duration. Seventeen children had moderate or severe hypertrichosis, this being more common in children of South Asian ethnicity (P < 0.0001). There was no correlation between ciclosporin exposure or duration and hypertrichosis. Finger-prick blood sampling may serve as a practical alternative to venepuncture in children receiving ciclosporin.
Similar articles
-
Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling.Ther Drug Monit. 2013 Feb;35(1):92-5. doi: 10.1097/FTD.0b013e31827d76ce. Ther Drug Monit. 2013. PMID: 23296096
-
Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study.Transpl Int. 2012 Apr;25(4):391-400. doi: 10.1111/j.1432-2277.2011.01409.x. Epub 2011 Dec 27. Transpl Int. 2012. PMID: 22211928 Clinical Trial.
-
Ciclosporin kinetics in children after stem cell transplantation.Br J Clin Pharmacol. 2008 Oct;66(4):539-45. doi: 10.1111/j.1365-2125.2008.03217.x. Epub 2008 Apr 30. Br J Clin Pharmacol. 2008. PMID: 18492124 Free PMC article.
-
Calcineurin inhibitors in pediatric renal transplant recipients.Paediatr Drugs. 2007;9(3):165-74. doi: 10.2165/00148581-200709030-00005. Paediatr Drugs. 2007. PMID: 17523697 Review.
-
Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.Clin Biochem. 2004 Jun;37(6):424-8. doi: 10.1016/j.clinbiochem.2004.04.001. Clin Biochem. 2004. PMID: 15183289 Review.
Cited by
-
Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.Bioanalysis. 2015;7(8):1037-58. doi: 10.4155/bio.15.35. Bioanalysis. 2015. PMID: 25966013 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous